StockMacro
Menu

Merit Medical Systems

$84.34 +31% in 6 monthsMarket cap $5.1B

MMSI on XNAS, Health Care, Merit Medical Systems Inc, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 8.4% to $416.2M and 12-month profit rose 35% to $160.1M.

  • WatchNews volume 21.0 times normal while shares fell 7.7% in one month
  • WatchCapital spending fell 45% to $12.3M in the latest quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
7,500
Website
merit.com
Listed
Nasdaq, US
Last results
29 Oct 2026
Next results
expected around 7 Jan 2027 (an estimate: a year ago it reported on 8 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $416.2M, net income $42.3M.
Quarter to 31 Dec 2021: revenue $278.5M, net income $20.6MQuarter to 31 Dec 2021: revenue $278.5M, net income $20.6MQuarter to 31 Mar 2022: revenue $275.4M, net income $10.5MQuarter to 31 Mar 2022: revenue $275.4M, net income $10.5MQuarter to 30 Jun 2022: revenue $295.0M, net income $15.3MQuarter to 30 Jun 2022: revenue $295.0M, net income $15.3MQuarter to 30 Sep 2022: revenue $287.2M, net income $15.3MQuarter to 30 Sep 2022: revenue $287.2M, net income $15.3MQuarter to 31 Dec 2022: revenue $293.4M, net income $33.4MQuarter to 31 Dec 2022: revenue $293.4M, net income $33.4MQuarter to 31 Mar 2023: revenue $297.6M, net income $20.7MQuarter to 31 Mar 2023: revenue $297.6M, net income $20.7MQuarter to 30 Jun 2023: revenue $320.1M, net income $20.2MQuarter to 30 Jun 2023: revenue $320.1M, net income $20.2MQuarter to 30 Sep 2023: revenue $315.2M, net income $25.8MQuarter to 30 Sep 2023: revenue $315.2M, net income $25.8MQuarter to 31 Dec 2023: revenue $324.5M, net income $27.6MQuarter to 31 Dec 2023: revenue $324.5M, net income $27.6MQuarter to 31 Mar 2024: revenue $323.5M, net income $28.2MQuarter to 31 Mar 2024: revenue $323.5M, net income $28.2MQuarter to 30 Jun 2024: revenue $338.0M, net income $35.7MQuarter to 30 Jun 2024: revenue $338.0M, net income $35.7MQuarter to 30 Sep 2024: revenue $339.8M, net income $28.4MQuarter to 30 Sep 2024: revenue $339.8M, net income $28.4MQuarter to 31 Dec 2024: revenue $355.2M, net income $27.9MQuarter to 31 Dec 2024: revenue $355.2M, net income $27.9MQuarter to 31 Mar 2025: revenue $355.4M, net income $30.1MQuarter to 31 Mar 2025: revenue $355.4M, net income $30.1MQuarter to 30 Jun 2025: revenue $382.5M, net income $32.6MQuarter to 30 Jun 2025: revenue $382.5M, net income $32.6MQuarter to 30 Sep 2025: revenue $384.2M, net income $27.8MQuarter to 30 Sep 2025: revenue $384.2M, net income $27.8MQuarter to 31 Dec 2025: revenue $393.9M, net income $38.0MQuarter to 31 Dec 2025: revenue $393.9M, net income $38.0MQuarter to 31 Mar 2026: revenue $381.9M, net income $41.0MQuarter to 31 Mar 2026: revenue $381.9M, net income $41.0MQuarter to 30 Jun 2026: revenue $418.8M, net income $38.8MQuarter to 30 Jun 2026: revenue $418.8M, net income $38.8MQuarter to 30 Sep 2026: revenue $416.2M, net income $42.3MQuarter to 30 Sep 2026: revenue $416.2M, net income $42.3M
31 Dec 2021RevenueNet incometallest bar $418.8M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$416.2M$42.3M
30 Jun 2026$418.8M$38.8M
31 Mar 2026$381.9M$41.0M
31 Dec 2025$393.9M$38.0M
30 Sep 2025$384.2M$27.8M
30 Jun 2025$382.5M$32.6M
31 Mar 2025$355.4M$30.1M
31 Dec 2024$355.2M$27.9M
30 Sep 2024$339.8M$28.4M
30 Jun 2024$338.0M$35.7M
31 Mar 2024$323.5M$28.2M
31 Dec 2023$324.5M$27.6M
30 Sep 2023$315.2M$25.8M
30 Jun 2023$320.1M$20.2M
31 Mar 2023$297.6M$20.7M
31 Dec 2022$293.4M$33.4M
30 Sep 2022$287.2M$15.3M
30 Jun 2022$295.0M$15.3M
31 Mar 2022$275.4M$10.5M
31 Dec 2021$278.5M$20.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.6B $1.5B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +9.1% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $160.1M $118.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $2.67 $1.95
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 49.4% 48.5% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 13.5% 11.3% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 9.9% 8.0% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 9.8% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $203.6M $206.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $503.6M $392.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $737.4M $732.9M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $233.9M $340.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.42 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $29.12
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 31.6 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 3.1 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.3 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.9 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Merit Medical SystemsMMSI (this company) $5.1B31.63.1+9.1%9.9%
HaemoneticsHAE $5.5B52.74.0+4.1%7.5%
MiniMedMMED $4.5Bloss1.4–-9.6%
ICU MedicalICUI $4.3B71.52.0-5.9%2.8%
HeartflowHTFL $4.1Bloss17.2+47%-33.1%
TeleflexTFX $6.4B21.02.8+21%13.5%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$2.1M

bought $0, sold $2.1M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+6.3%

420 13F filers vs 395

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

62.4M shares held by 13F filers (30 Sep 2026) of 59.9M outstanding (27 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

6.7%

4.0M shares sold short (30 Oct 2026) of 59.9M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.1

4.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.3%

3.8M shares sold short in the report before, 4.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

67%

67% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

97

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+8.4%

$416.2M vs $384.2M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-45%

$12.3M vs $22.4M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$10K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

22

22 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

22×

22 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New institutional positions 68, 1.5× a year earlier

Price $84.34 on 20 Nov 2026, -0.6% over 12 months (12-month range $60.31 to $94.20)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $4.1M in the last 12 months (the 12 months before: -$27.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months, -33% on the 12 months before.
Revenue per quarter. Revenue $416.2M in the latest quarter, +8.4% on a year earlier.
Capital spending per quarter. Capital spending $12.3M in the latest quarter, -45% on a year earlier.
Institutional holders (13F filers). 420 13F filers reported holding it in the latest 13F quarter, +17% on a year earlier.
Federal obligations. Federal obligations: $6K published in the last 12 months, -54% on the 12 months before.
Lobbying spend. Lobbying spend: $10K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
22 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 68 vs usual 46.50 (2026-09-30); 1.5x the same period a year earlier
20 Aug 20268-K and other filingsDirector or officer change
20 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 20268-K and other filingsDirector or officer change
19 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 May 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 349K)
8 Jan 20268-K and other filingsDirector or officer change
8 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Nov 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 22.4M vs usual 10.0M (2025-09-30); 2.4x the same period a year earlier
9 Oct 20258-K and other filingsDirector or officer change
9 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Jul 20258-K and other filingsDirector or officer change
11 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Apr 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 21.1M vs usual 9.0M (2025-03-31); 1.8x the same period a year earlier
19 Dec 20248-K and other filingsDirector or officer change
19 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 20248-K and other filingsDirector or officer change
16 May 20248-K and other filingsDirector or officer change
16 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Apr 2024Sharp changeShort interest spike: short interest spike, 2.3M vs usual 886K (2024-03-15); 3.3x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 2.4M vs usual 850K (2024-02-29); 3.6x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 2.2M vs usual 811K (2024-02-15); 3.6x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 2.2M vs usual 785K (2024-01-31); 3.7x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 2.2M vs usual 755K (2024-01-12); 3.5x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 2.1M vs usual 723K (2023-12-29); 3.3x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 1.9M vs usual 702K (2023-12-15); 3.3x the same period a year earlier
8 Jun 20238-K and other filingsDirector or officer change
8 Jun 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Nov 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 15.8M vs usual 7.8M (2022-09-30); 2.3x the same period a year earlier
22 Apr 20228-K and other filingsDirector or officer change
22 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jun 2022: -$395K published
Month from 1 Aug 2022: -$3.6M published
Month from 1 Mar 2023: -$6.5M published
Month from 1 Aug 2023: -$2.1M published
Month from 1 Jan 2024: -$1.6M published
Month from 1 Mar 2024: -$3.8M published
Month from 1 Jun 2024: -$614K published
Month from 1 Jul 2024: -$1.1M published
Month from 1 Nov 2024: -$5.2M published
Month from 1 Mar 2025: -$13.4M published
Month from 1 Apr 2025: -$523K published
Month from 1 May 2025: -$4.0M published
Month from 1 Jun 2025: -$4.0M published
Month from 1 Aug 2025: -$472K published
Month from 1 Nov 2025: -$5.2M published
Month from 1 Jan 2026: -$450K published
Month from 1 May 2026: $260K published
Month from 1 Aug 2026: -$2.5M published
Month from 1 Nov 2026: -$1.4M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 2 published
Quarter from 1 Oct 2022: 2 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 2 published
Quarter from 1 Jul 2026: 2 published
Revenue per quarter
Quarter ended 31 Dec 2021: $278.5M, +7.9% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $275.4M, +11% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $295.0M, +5.2% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $287.2M, +7.5% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $293.4M, +5.4% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $297.6M, +8.0% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $320.1M, +8.5% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $315.2M, +9.8% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $324.5M, +11% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $323.5M, +8.7% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $338.0M, +5.6% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $339.8M, +7.8% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $355.2M, +9.4% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $355.4M, +9.8% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $382.5M, +13% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $384.2M, +13% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $393.9M, +11% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $381.9M, +7.5% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $418.8M, +9.5% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $416.2M, +8.4% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $8.3M, -20% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $9.5M, +54% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $7.2M, +8.9% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $15.8M, +132% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $12.5M, +50% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $12.8M, +34% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $5.8M, -20% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $8.6M, -46% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $7.1M, -43% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $11.7M, -8.6% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $10.6M, +84% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $9.4M, +8.9% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $3.5M, -51% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $21.1M, +80% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $13.8M, +29% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $22.4M, +140% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $24.5M, +605% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $16.0M, -24% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $17.3M, +26% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $12.3M, -45% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 244; public on 14 Feb 2022
31 Mar 2022 report: 254; public on 16 May 2022
30 Jun 2022 report: 248; public on 15 Aug 2022
30 Sep 2022 report: 222; public on 14 Nov 2022
31 Dec 2022 report: 253; public on 14 Feb 2023
31 Mar 2023 report: 269; public on 15 May 2023
30 Jun 2023 report: 288; public on 14 Aug 2023
30 Sep 2023 report: 253; public on 14 Nov 2023
31 Dec 2023 report: 270; public on 14 Feb 2024
31 Mar 2024 report: 291; public on 15 May 2024
30 Jun 2024 report: 302; public on 14 Aug 2024
30 Sep 2024 report: 357; public on 14 Nov 2024
31 Dec 2024 report: 370; public on 14 Feb 2025
31 Mar 2025 report: 360; public on 15 May 2025
30 Jun 2025 report: 358; public on 14 Aug 2025
30 Sep 2025 report: 359; public on 14 Nov 2025
31 Dec 2025 report: 379; public on 17 Feb 2026
31 Mar 2026 report: 388; public on 15 May 2026
30 Jun 2026 report: 395; public on 14 Aug 2026
30 Sep 2026 report: 420; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $187K published
Month from 1 Feb 2022: $104K published
Month from 1 Mar 2022: $91K published
Month from 1 Apr 2022: $16K published
Month from 1 May 2022: $162 published
Month from 1 Jul 2022: $210 published
Month from 1 Aug 2022: $55K published
Month from 1 Sep 2022: -$8K published
Month from 1 Nov 2022: $64K published
Month from 1 May 2023: $9K published
Month from 1 Jul 2023: $107K published
Month from 1 Aug 2023: $108K published
Month from 1 Sep 2023: $145K published
Month from 1 Oct 2023: $72K published
Month from 1 Dec 2023: $208K published
Month from 1 Aug 2024: $99K published
Month from 1 Feb 2025: $1K published
Month from 1 Mar 2025: $210 published
Month from 1 Jul 2025: $14K published
Month from 1 Nov 2025: -$1K published
Month from 1 Feb 2026: -$450 published
Month from 1 Jun 2026: -$500 published
Month from 1 Aug 2026: $7K published
Month from 1 Oct 2026: $0 published
Lobbying spend
Quarter from 1 Apr 2022: $30K published
Quarter from 1 Jan 2023: $30K published
Quarter from 1 Jul 2023: $10K published
Quarter from 1 Oct 2023: $10K published
Quarter from 1 Jan 2024: $10K published
Quarter from 1 Apr 2024: $10K published
Quarter from 1 Oct 2026: $10K published

What is unusual now

  • Made public in the last 90 days: it saw 68 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year.
  • Many funds opening a new position: saw 68 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year Public on 16 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $4.1M in the last 12 months (the 12 months before: -$27.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months, -33% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 2 sales, $2.1M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Nov 2026Brian G. LloydCHIEF LEGAL OFFICER, SECRETARYSellplanned in advance (10b5-1); after exercising options16,722$86.32$1.4MForm 4
25 Aug 2026Neil W. PetersonCHIEF OPERATING OFFICERSell7,500$90.45$678KForm 4
5 Aug 2026Neil W. PetersonCHIEF OPERATING OFFICERSell21,449$85.00$1.8MForm 4
13 May 2026Christian Adam SmithChief Commercial OfficerBuy1,626$61.00$99KForm 4
11 May 2026Lynne N. WardDirectorSell5,000$62.61$313KForm 4
11 May 2026Brian G. LloydCHIEF LEGAL OFFICER, SECRETARYBuy2,000$62.63$125KForm 4
7 May 2026Raul Parra Jr.CFO AND TREASURERBuy1,500$61.01$92KForm 4
7 May 2026Martha Goldberg AronsonPresident and CEOBuy2,000$60.44$121KForm 4

420 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 68 opened a position, 49 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.9.5M15.8%$818.5M+28K+0.3%
Vanguard Portfolio Management LLC3.4M5.71%$295.1M-52K-1.5%
Vanguard Capital Management LLC2.6M4.32%$223.4M+5640%
State Street Corp2.5M4.10%$211.9M-17K-0.7%
Fuller & Thaler Asset Management, Inc.2.2M3.60%$185.8M+542K+34%
Dimensional Fund Advisors LP1.7M2.76%$142.7M+196K+13%
Geode Capital Management, LLC1.6M2.70%$139.4M-9,222-0.6%
Conestoga Capital Advisors, LLC1.5M2.52%$130.2M-470K-24%
FMR LLC (Fidelity)1.4M2.41%$124.6M+432K+43%
Neuberger Berman Group LLC1.4M2.28%$117.7M+363K+36%

Company events

All 47 company events

In 12 months: 3 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
20 Aug 2026Director or officer change8-K
19 May 2026Director or officer changeSame filing: changed its bylaws or fiscal year, shareholder vote results8-K
8 Jan 2026Director or officer change8-K
9 Oct 2025Director or officer change8-K
11 Jul 2025Director or officer change8-K
20 May 2025Signed a major agreement8-K
19 Dec 2024Director or officer change8-K
18 Sep 2024Signed a major agreement8-K

97 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 20%, Operations & administration 9%, Manufacturing & production 8%, Supply chain & procurement 7%.

PostedJobLocation
21 Nov 2026or earlier11165H - Operations Associate I (Hourly)Operations & administrationRichmond, VA
21 Nov 2026or earlier11165H - Operations Associate I (Hourly)Operations & administrationRichmond, VA
21 Nov 2026or earlier11165H - Operations Associate I (Hourly)Operations & administrationRichmond, VA
21 Nov 2026or earlier11165H - Operations Associate I (Hourly)Operations & administrationRichmond, VA
21 Nov 2026or earlierFacilities Maintenance SpecialistFacilities & constructionRichmond, VA
21 Nov 2026or earlierJanitorFacilities & constructionRichmond, VA
21 Nov 2026or earlierMA SupervisorBeijing, China
21 Nov 2026or earlierLogistics Clerk ISupply chain & procurementRichmond, VA

Reported lobbying spend: $10K in Q3 2026, $10K in Q1 2024. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
30 Jun 2017EndedMerit Medical Systems, Inc.its own lobbyistsNot statedFiling
1 Jan 2010NewMerit Medical Systems, Inc.its own lobbyistsHeathcare reform, Research & development tax credit, Regulatory issues with the FDABudget, Manufacturing, Taxation, Copyright/patents, ECN, Health issues, Consumer safety, Labor, TradeFiling

The 5 newest of 127 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Jan 2020confirmed

Confirmed across sources Lobbying and Short interest and volume

Merit Medical Systems (MMSI): lobbying on a new issue, while it had 7.0M shares sold short in the 15 Jan 2020 report, 2.6× the same report last year. Two unrelated kinds of activity within 74 days.

  • Lobbying: Lobbying on a new issue, became public on 3 Jan 2020
  • Short interest and volume: Short interest spike, became public on 11 Jan 2020
  • Short interest and volume: Short interest spike, became public on 28 Jan 2020
  • Short interest and volume: Short interest spike, became public on 12 Feb 2020
  • Short interest and volume: Short interest spike, became public on 27 Feb 2020
  • Short interest and volume: Short interest spike, became public on 11 Mar 2020
2019-01-15: 2.6M2019-01-31: 2.6M2019-02-15: 2.7M2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M2020-01-15: 7.0M
The 15 Jan 2020 report against the 24 reports before it. this reportearliernormal: 3.6M
See the evidence (6 changes)

Lobbying: Lobbying on a new issue became public on 3 Jan 2020

Merit Medical Systems lobbying on a new issue.

New
['TRD']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12718068

Short interest and volume: Short interest spike became public on 11 Jan 2020

Merit Medical Systems had 6.0M shares sold short in the 31 Dec 2019 report, 2.2× the same report last year.

This period
6.0M (the 31 Dec 2019 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
252K
How far from its usual level
+6.5
Same report last year
2.7M
History used
732 days
2018-12-31: 2.7M2019-01-15: 2.6M2019-01-31: 2.6M2019-02-15: 2.7M2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M
the 31 Dec 2019 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Jan 2020

Merit Medical Systems had 7.0M shares sold short in the 15 Jan 2020 report, 2.6× the same report last year.

This period
7.0M (the 15 Jan 2020 report)
Normal report (median of 24 earlier)
3.6M
Typical spread (median absolute deviation)
233K
How far from its usual level
+9.6
Same report last year
2.6M
History used
747 days
2019-01-15: 2.6M2019-01-31: 2.6M2019-02-15: 2.7M2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M2020-01-15: 7.0M
the 15 Jan 2020 report24 earlier reportsnormal: 3.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Feb 2020

Merit Medical Systems had 5.6M shares sold short in the 31 Jan 2020 report, 2.2× the same report last year.

This period
5.6M (the 31 Jan 2020 report)
Normal report (median of 24 earlier)
3.7M
Typical spread (median absolute deviation)
310K
How far from its usual level
+4.3
Same report last year
2.6M
History used
763 days
2019-01-31: 2.6M2019-02-15: 2.7M2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M2020-01-15: 7.0M2020-01-31: 5.6M
the 31 Jan 2020 report24 earlier reportsnormal: 3.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Feb 2020

Merit Medical Systems had 5.7M shares sold short in the 14 Feb 2020 report, 2.1× the same report last year.

This period
5.7M (the 14 Feb 2020 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
368K
How far from its usual level
+3.5
Same report last year
2.7M
History used
777 days
2019-02-15: 2.7M2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M2020-01-15: 7.0M2020-01-31: 5.6M2020-02-14: 5.7M
the 14 Feb 2020 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Mar 2020

Merit Medical Systems had 5.7M shares sold short in the 28 Feb 2020 report, 2.1× the same report last year.

This period
5.7M (the 28 Feb 2020 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
368K
How far from its usual level
+3.6
Same report last year
2.8M
History used
791 days
2019-02-28: 2.8M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.3M2019-05-15: 3.5M2019-05-31: 3.8M2019-06-14: 3.6M2019-06-28: 3.8M2019-07-15: 3.8M2019-07-31: 3.4M2019-08-15: 3.6M2019-08-30: 3.9M2019-09-13: 3.5M2019-09-30: 3.8M2019-10-15: 3.8M2019-10-31: 4.0M2019-11-15: 4.4M2019-11-29: 4.1M2019-12-13: 4.8M2019-12-31: 6.0M2020-01-15: 7.0M2020-01-31: 5.6M2020-02-14: 5.7M2020-02-28: 5.7M
the 28 Feb 2020 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Institutional holdings change

    saw 68 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year.

    Same quarter last year: 44; its normal quarter is 46.5.

    See the evidence
    This period
    68 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    46.5
    Typical spread (median absolute deviation)
    3.5
    How far from its usual level
    +4.1
    Same quarter last year
    44
    History used
    4,748 days
    2024-09-30: 742024-12-31: 472025-03-31: 442025-06-30: 422025-09-30: 442025-12-31: 462026-03-31: 592026-06-30: 562026-09-30: 68
    the quarter ended 30 Sep 20268 earlier quartersnormal: 46.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 20 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 20 Aug 2026Filings record

    Director or officer change

  4. 19 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 19 May 2026Filings record

    Director or officer change

  6. 14 May 2026Insiders record

    Smith Christian Adam (Chief Commercial Officer) bought 1,626 shares of MMSI ($99,186) (dated 13 May 2026)

  7. 12 May 2026Insiders record

    Lloyd Brian G. (CHIEF LEGAL OFFICER, SECRETARY) bought 2,000 shares of MMSI ($125,260) (dated 11 May 2026)

  8. 8 May 2026Insiders change

    had 3 insiders buy $349K of its shares on the open market within 30 days (3 filings).

    Who bought: Voigt Michel J., Aronson Martha Goldberg, Parra Raul Jr..

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $349K
    Window
    8 Apr 2026 to 8 May 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  9. 8 May 2026Insiders record

    Parra Raul Jr. (CFO AND TREASURER) bought 1,500 shares of MMSI ($91,515) (dated 7 May 2026)

  10. 8 May 2026Insiders record

    Aronson Martha Goldberg (President and CEO) bought 2,000 shares of MMSI ($120,880) (dated 7 May 2026)

  11. 8 May 2026Insiders record

    Voigt Michel J. (CHIEF HUMAN RESOURCES OFFICER) bought 2,250 shares of MMSI ($136,462) (dated 7 May 2026)

  12. 8 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 8 Jan 2026Filings record

    Director or officer change

  14. 4 Nov 2025Financials change

    spent $22.4M on capital projects in the quarter ended 30 Sep 2025, 2.4× the same quarter last year.

    Same quarter last year: $9.4M; its normal quarter is $10.0M.

    See the evidence
    This period
    $22.4M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $10.0M
    Typical spread (median absolute deviation)
    $2.3M
    How far from its usual level
    +3.7
    Same quarter last year
    $9.4M
    History used
    5,479 days
    2023-09-30: $8.6M2023-12-31: $7.1M2024-03-31: $11.7M2024-06-30: $10.6M2024-09-30: $9.4M2024-12-31: $3.5M2025-03-31: $21.1M2025-06-30: $13.8M2025-09-30: $22.4M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $10.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  15. 9 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 9 Oct 2025Filings record

    Director or officer change

  17. 11 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 11 Jul 2025Filings record

    Director or officer change

  19. 29 Apr 2025Financials change

    spent $21.1M on capital projects in the quarter ended 31 Mar 2025, 1.8× the same quarter last year.

    Same quarter last year: $11.7M; its normal quarter is $9.0M.

    See the evidence
    This period
    $21.1M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $9.0M
    Typical spread (median absolute deviation)
    $2.3M
    How far from its usual level
    +3.6
    Same quarter last year
    $11.7M
    History used
    5,296 days
    2023-03-31: $12.8M2023-06-30: $5.8M2023-09-30: $8.6M2023-12-31: $7.1M2024-03-31: $11.7M2024-06-30: $10.6M2024-09-30: $9.4M2024-12-31: $3.5M2025-03-31: $21.1M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $9.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  20. 19 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 19 Dec 2024Filings record

    Director or officer change

  22. 21 May 2024Filings record

    Director or officer change

  23. 16 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 16 May 2024Filings record

    Director or officer change

  25. 27 Mar 2024Short interest and volume change

    had 2.3M shares sold short in the 15 Mar 2024 report, 3.3× the same report last year.

    Same report last year: 695K; its normal report is 886K.

    See the evidence
    This period
    2.3M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    886K
    Typical spread (median absolute deviation)
    184K
    How far from its usual level
    +5.0
    Same report last year
    695K
    History used
    2,268 days
    2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M2024-01-12: 2.2M2024-01-31: 2.2M2024-02-15: 2.2M2024-02-29: 2.4M2024-03-15: 2.3M
    the 15 Mar 2024 report24 earlier reportsnormal: 886K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 12 Mar 2024Short interest and volume change

    had 2.4M shares sold short in the 29 Feb 2024 report, 3.6× the same report last year.

    Same report last year: 652K; its normal report is 850K.

    See the evidence
    This period
    2.4M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    850K
    Typical spread (median absolute deviation)
    175K
    How far from its usual level
    +5.9
    Same report last year
    652K
    History used
    2,253 days
    2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M2024-01-12: 2.2M2024-01-31: 2.2M2024-02-15: 2.2M2024-02-29: 2.4M
    the 29 Feb 2024 report24 earlier reportsnormal: 850K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 28 Feb 2024Short interest and volume change

    had 2.2M shares sold short in the 15 Feb 2024 report, 3.6× the same report last year.

    Same report last year: 611K; its normal report is 811K.

    See the evidence
    This period
    2.2M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    811K
    Typical spread (median absolute deviation)
    160K
    How far from its usual level
    +6.0
    Same report last year
    611K
    History used
    2,239 days
    2023-02-15: 611K2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M2024-01-12: 2.2M2024-01-31: 2.2M2024-02-15: 2.2M
    the 15 Feb 2024 report24 earlier reportsnormal: 811K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Feb 2024Short interest and volume change

    had 2.2M shares sold short in the 31 Jan 2024 report, 3.7× the same report last year.

    Same report last year: 606K; its normal report is 785K.

    See the evidence
    This period
    2.2M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    785K
    Typical spread (median absolute deviation)
    135K
    How far from its usual level
    +7.2
    Same report last year
    606K
    History used
    2,224 days
    2023-01-31: 606K2023-02-15: 611K2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M2024-01-12: 2.2M2024-01-31: 2.2M
    the 31 Jan 2024 report24 earlier reportsnormal: 785K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 25 Jan 2024Short interest and volume change

    had 2.2M shares sold short in the 12 Jan 2024 report, 3.5× the same report last year.

    Same report last year: 640K; its normal report is 755K.

    See the evidence
    This period
    2.2M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    755K
    Typical spread (median absolute deviation)
    129K
    How far from its usual level
    +7.8
    Same report last year
    640K
    History used
    2,205 days
    2023-01-13: 640K2023-01-31: 606K2023-02-15: 611K2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M2024-01-12: 2.2M
    the 12 Jan 2024 report24 earlier reportsnormal: 755K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 11 Jan 2024Short interest and volume change

    had 2.1M shares sold short in the 29 Dec 2023 report, 3.3× the same report last year.

    Same report last year: 637K; its normal report is 723K.

    See the evidence
    This period
    2.1M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    723K
    Typical spread (median absolute deviation)
    104K
    How far from its usual level
    +9.0
    Same report last year
    637K
    History used
    2,191 days
    2022-12-30: 637K2023-01-13: 640K2023-01-31: 606K2023-02-15: 611K2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M2023-12-29: 2.1M
    the 29 Dec 2023 report24 earlier reportsnormal: 723K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 28 Dec 2023Short interest and volume change

    had 1.9M shares sold short in the 15 Dec 2023 report, 3.3× the same report last year.

    Same report last year: 580K; its normal report is 702K.

    See the evidence
    This period
    1.9M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    702K
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +8.9
    Same report last year
    580K
    History used
    2,177 days
    2022-12-15: 580K2022-12-30: 637K2023-01-13: 640K2023-01-31: 606K2023-02-15: 611K2023-02-28: 652K2023-03-15: 695K2023-03-31: 593K2023-04-14: 651K2023-04-28: 825K2023-05-15: 773K2023-05-31: 708K2023-06-15: 737K2023-06-30: 616K2023-07-14: 649K2023-07-31: 664K2023-08-15: 973K2023-08-31: 1.0M2023-09-15: 1.0M2023-09-29: 922K2023-10-13: 874K2023-10-31: 797K2023-11-15: 906K2023-11-30: 897K2023-12-15: 1.9M
    the 15 Dec 2023 report24 earlier reportsnormal: 702K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 8 Jun 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 8 Jun 2023Filings record

    Director or officer change

  34. 1 Nov 2022Financials change

    spent $15.8M on capital projects in the quarter ended 30 Sep 2022, 2.3× the same quarter last year.

    Same quarter last year: $6.8M; its normal quarter is $7.8M.

    See the evidence
    This period
    $15.8M (the quarter ended 30 Sep 2022)
    Normal quarter (median of 8 earlier)
    $7.8M
    Typical spread (median absolute deviation)
    $1.4M
    How far from its usual level
    +3.9
    Same quarter last year
    $6.8M
    History used
    4,383 days
    2020-09-30: $9.8M2020-12-31: $10.4M2021-03-31: $6.2M2021-06-30: $6.6M2021-09-30: $6.8M2021-12-31: $8.3M2022-03-31: $9.5M2022-06-30: $7.2M2022-09-30: $15.8M
    the quarter ended 30 Sep 20228 earlier quartersnormal: $7.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  35. 22 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 22 Apr 2022Filings record

    Director or officer change

  37. 22 Oct 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 22 Oct 2021Filings record

    Director or officer change

  39. 23 Jun 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 23 Jun 2021Filings record

    Director or officer change

Showing the newest 40 of 70 entries; narrow the window or the kind of data to see older ones.

Not listed: 260 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000856982
Ticker
MMSI
Domain
merit.com
Employer name
Merit Medical Systems, Inc. (1 unverified)
Hq location
UT|SOUTH JORDAN|84095 (1 unverified)
Lobbying client
merit medical systems
Name
Biolife Delaware, LLC, Biolife Management Services, LLC, BioSphere Medical, Inc, BioSphere Medical Japan, Inc and 49 more
Uei
KGGGM76DYEB9
  • DOL H-1B labor condition applications and PERM certifications50 data points5 Apr 2021 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)2 records, 165 data points1 Jan 2010 to 30 Sep 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)158 records5 Feb 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1159 data points31 Dec 2008 to 27 Oct 2026
  • SEC Form 4 insider transactions138 records, 456 data points3 Mar 2016 to 17 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards2706 data points1 Oct 2007 to 20 Oct 2026